Regulatory briefing
LATEST ALERTS
-
Australia Greens drawing up bill to legalise recreational cannabis…
-
Italy Right-wing government spells bad news for cannabis…
-
Brazil Medical cannabis cannot be sold through delivery services…
-
Colombia President Petro urged to support bill on recreational cannabis…
-
Arkansas - United States Votes will be counted in ballot measure to legalise recreational cannabis…
-
Paraguay Discussion to improve availability of medicinal cannabis…
-
Canada Legislative review of the Cannabis Act launched…
-
World Legalising recreational cannabis ‘is a threat to the consensus’…
-
Spain Pharmacists call for more evidence on medical cannabis…
-
Minnesota - United States Company sues state over ‘discrimination’ against cannabis-derived edibles (...)
-
Oklahoma - United States Bid to legalise recreational cannabis misses the ballot…
-
Czech Republic A regulated recreational cannabis market within three years?
HHC and other intoxicating cannabinoids move within legal limbo in Europe
Written by Tiziana Cauli || 16th September 2022 || Regulatory briefing |
As debate over the legalisation of recreational cannabis involves a growing number of European countries, the commercial demand for legal psychoactive alternatives to controlled cannabinoid variants is on the rise ...
Kushly must pay refunds through FTC over health claims, others may follow
Written by CBD-Intel || 15th September 2022 || Regulatory briefing |
Kushly is the first – but potentially not the last – CBD company to be forced to provide refunds to consumers through the US Federal Trade Commission (FTC) ...
With midterms coming, what has the Biden administration ever done for us?
Written by Lorraine Mullaney || 15th September 2022 || Regulatory briefing |
As the US midterm elections approach, questions are being raised about the actions the Biden administration has taken to meet campaign promises regarding drug reform ...
Where the parties stand on cannabis ahead of Italian elections this month
Written by CBD-Intel || 12th September 2022 || Regulatory briefing |
The right-wing coalition parties which look most likely to triumph in Italy’s coming elections take a uniformly hard line on drug policy – which could be bad news for the cannabinoids industry ...
German hemp farm raided on grounds crop exceeds country’s 0.2% THC limit
Written by CBD-Intel || 12th September 2022 || Regulatory briefing |
More than two dozen officers carried out a surprise raid on a farm in Dithmarschen on 30th August as part of “an investigation into the joint illegal trade of large quantities of narcotics”, according to the Itzehoe Police Department...
Calls for changes in Canadian cannabis laws as strikes cause supply issues
Written by CBD-Intel || 9th September 2022 || Regulatory briefing |
Canada’s cannabis industry is calling for changes in the way cannabis products are distributed and sold in some parts of the country after labour disputes in two provinces have led to strikes and forced some stores to close...
Coming together over cannabis: is support becoming a bipartisan issue?
Written by Freddie Dawson || 8th September 2022 || Blog , Regulatory briefing |
Once mainly the purview of fringe leftists, support for cannabis continues to become more of a bipartisan issue ...
President puts forward bill to legalise recreational cannabis in Costa Rica
Written by CBD-Intel || 6th September 2022 || Regulatory briefing |
Costa Rica will look to legalise recreational cannabis with a bill presented to Congress ahead of extraordinary legislative sessions in November, president Rodrigo Chaves announced ...
Minnesota Republicans told they should have been careful what they voted for
Written by CBD-Intel || 5th September 2022 || Regulatory briefing |
Some Minnesota legislators have expressed regret after failing to realise that a law clarifying rules around hemp products would permit the sale of edible products with THC levels similar to those seen in recreational cannabis ...
CBD is no more a drug than honey is, industry expert tells FDA science board
Written by CBD-Intel || 5th September 2022 || Regulatory briefing |
If CBD is to be regulated as a drug, then so should honey. That was one of the views put by industry members to the US Food and Drug Administration (FDA) Science Board public advisory committee ...
Colombia sees explosion in medical cannabis exports since rules changed
Written by CBD-Intel || 2nd September 2022 || Regulatory briefing |
The 1st April change to permit the export of medical cannabis from Colombia has sparked an immediate boom in shipments from the South American country ...
Legal challenge coming after Ghana’s Supreme Court halts hemp licensing
Written by CBD-Intel || 31st August 2022 || Regulatory briefing |
Cannabis activists are set to challenge a ruling by the Supreme Court of Ghana which invalidated a section of the country’s Narcotic Control Commission Act 2020 that would have enabled the licensing of hemp production ...
Colombia’s new president out to end ‘war on drugs’ and legalise recreational use
Written by CBD-Intel || 30th August 2022 || Regulatory briefing |
Colombia’s first leftist president says the “war on drugs” has failed and it is now time to look to formerly prohibited crops such as cannabis to boost the country’s economy and bring some justice to victims ...
State legislatures urge Washington to support moves to legalise cannabis
Written by CBD-Intel || 30th August 2022 || Regulatory briefing |
The Republican-influenced National Conference of State Legislatures (NCSL) has explicitly called on the US federal government to support cannabis legalisation measures ...
High costs result in further delays to Belize’s cannabis referendum
Written by CBD-Intel || 29th August 2022 || Regulatory briefing |
Belize will defer a referendum vote on the legalisation of recreational cannabis brought about by opposition from national church leaders in the country, officials have said in a joint statement issued on 4th August ...
A breathalyser for cannabis impairment? The search to find a reliable test goes on
Written by Lorraine Mullaney || 23rd August 2022 || Regulatory briefing |
US law enforcement is working alongside toxicologists and cannabis breathalyser developer Cannabix Technologies to test and compare various methods of detecting cannabis intoxication ...
Move towards granting new US research cannabis licence following slow start
Written by Lorraine Mullaney || 22nd August 2022 || Regulatory briefing |
The US Drug Enforcement Administration (DEA) has issued a pre-solicitation notice to approved medical cannabis producers, the next step in securing new suppliers of cannabis for research purposes after a monopoly was ended ...
Medical cannabis advocates in the Philippines find government support
Written by CBD-Intel || 19th August 2022 || Regulatory briefing |
Medical cannabis advocates in the Philippines have found an ally in a young senator, but there is still much to do ...
US FDA gets into local enforcement now ‘rather than play whack-a-mole later’
Written by CBD-Intel || 19th August 2022 || Regulatory briefing |
Recent unusual activity by the US Food and Drug Administration (FDA) could be an attempt to strike a heavy blow now in order to avoid continuing to play whack-a-mole with enforcement as time goes on ...
Views invited as Health Canada moves on prescription-free CBD product sales
Written by CBD-Intel || 18th August 2022 || Regulatory briefing |
Canada has moved a step closer to allowing some health products containing CBD to be sold without a prescription as Health Canada embarks on consultation over regulatory plans ...
Pennsylvania banking bill welcomed, but it’s federal legislation they all want
Written by CBD-Intel || 17th August 2022 || Regulatory briefing |
A new state law will help shield financial companies in Pennsylvania from prosecution over transactions with legal cannabis companies. But industry leaders say more protection is needed after a federal bill was halted ...
US House approves cannabis research bill but hopes for reform remain low
Written by Lorraine Mullaney || 16th August 2022 || Regulatory briefing |
Members of the US House of Representatives have approved a bill to expand and streamline research into CBD and cannabis. The bill is now heading for the Senate and is expected to reach president Joe Biden’s desk ...
US legislators seek to amend cannabis advertising laws ahead of midterms
Written by CBD-Intel || 15th August 2022 || Regulatory briefing |
Advertising of cannabis products looks set to be a potential battleground as the US legislature heads towards midterm elections later this year ...
US House agriculture committee hears wish list of changes to 2023 Farm Bill
Written by Tiziana Cauli || 12th August 2022 || Regulatory briefing |
A group of US Congress members, state agriculture commissioners, researchers and industry representatives told a Congressional committee what changes to the law they would include in the upcoming 2023 Farm Bill if given the chance ...
Trouble in Lima – hemp bill’s chances tied up in Peru’s congressional crisis
Written by Freddie Dawson || 10th August 2022 || Blog , Regulatory briefing |
New legislation has been put forward in Peru to establish a framework for the production and commercialisation of hemp – but what are its chances of passing in a period of political turmoil? ...
Three nations aiming to lead EU states toward joined-up cannabis reforms
Written by CBD-Intel || 9th August 2022 || Regulatory briefing |
Germany, Luxembourg and Malta have taken the first step towards working together on the legalisation and regulation of recreational cannabis, leading a wave of potential reform across the EU ...
US DEA makes U-turn on psychedelics as senators call for more research support
Written by Lorraine Mullaney || 8th August 2022 || Regulatory briefing |
The US Drug Enforcement Administration (DEA) has withdrawn its proposal to effectively ban five psychedelic compounds after receiving significant opposition from the research and advocacy community ...
Peruvian initiative aims to open up hemp industry for rural ‘artisan’ production
Written by CBD-Intel || 5th August 2022 || Regulatory briefing |
A bill put forward in Peru seeks to establish regulation that would allow for the production and commercialisation of industrial hemp in the South American country ...
Spain’s first medical cannabis regulation could boost sector despite restrictions
Written by Tiziana Cauli || 29th July 2022 || Regulatory briefing |
Patients in Spain will soon be able to access cannabis in pharmacies with a medical prescription as the government is about to introduce new legislation ...
CBD and cannabis on Australia’s horizon – but don’t thank Labor government
Written by Tiziana Cauli || 25th July 2022 || Regulatory briefing |
CBD products may start to appear on the Australian market but it will not be due to any action taken by the newly elected Labor government, according to industry insiders and experts ...
Argentina’s hemp industry hoping new legal framework will encompass delta-8
Written by CBD-Intel || 19th July 2022 || Regulatory briefing |
The Argentine hemp industry is hopeful that sales of delta-8 THC hemp products will be formally permitted under the country’s new legal framework for cannabinoids ...
A ‘milestone’ for psychedelics as clinical trial begins in US with FDA’s blessing
Written by Freddie Dawson || 18th July 2022 || Regulatory briefing |
As the first federally approved psychedelics clinical trial begins in the US, there is broad but not total agreement among official bodies over legalising research into hallucinogenic substances ...
US 0.3% THC limit challenge dismissed: what could it mean for hemp producers?
Written by CBD-Intel || 15th July 2022 || Regulatory briefing |
Hemp producers have lost an important challenge on the 0.3% THC threshold for hemp-derived products in the US, potentially making producers liable if they go over the threshold during production, whether or not the end product meets the...
Cannabis or marijuana? Why it matters what name you (and the law) know it by
Written by Freddie Dawson || 13th July 2022 || Blog , Regulatory briefing |
There is quite a bit of baggage in how reference is made to the Cannabis sativa plant – as demonstrated by what's behind a new change to the law in the US state of Washington ...
British Standards moves to fill the safety and quality gap on CBD vaping products
Written by Antonia di Lorenzo || 12th July 2022 || Regulatory briefing |
The British Standards Institution (BSI) has developed a fast-track informal standard, PAS 13956, to address quality, performance and safety issues of CBD vape products ...
Incoming Colombian government has big plans for the country’s cannabis industry
Written by CBD-Intel || 8th July 2022 || Regulatory briefing |
Colombian president-elect Gustavo Petro says he will prioritise development of the nation’s cannabis industry and is promising that he will improve regulation, expand the existing legal framework and clarify production regulation as well as decriminalise consumption ...
No magic solution: EFSA ingestible CBD safety concerns won’t be resolved quickly
Written by Freddie Dawson || 1st July 2022 || Blog , Regulatory briefing |
It looks like there will be no easy or quick solutions to addressing the data gaps the European Food Safety Authority (EFSA) requires to reach a conclusion on the safety of CBD as an ingestible ingredient ...
UK FSA issues final final list of products linked to a CBD novel food application
Written by Freddie Dawson || 30th June 2022 || Regulatory briefing |
The UK Food Standards Agency (FSA) has published its final public list of CBD products that can be marketed in England and Wales – and again it's twice as long as it was ...
EU novel food applications: the science behind what EFSA says it wants to know
Written by CBD-Intel || 27th June 2022 || Regulatory briefing |
The European Food Safety Authority wants more safety data before it approves CBD products as novel food. This is what it wants to know, and why, along with a summary of the science on each point ...
State AGs urge US Congress leaders to take action on ‘copycat’ THC edibles
Written by Lorraine Mullaney || 24th June 2022 || Regulatory briefing |
A bipartisan group of 23 US state attorneys general have joined calls to halt the sale of edible cannabinoid-containing products that imitate the look of well-known brands ...
Recreational cannabis remains illegal in Delaware despite unusual efforts
Written by CBD-Intel || 24th June 2022 || Regulatory briefing |
A bid to legalise recreational cannabis in the US state of Delaware failed when lawmakers fell just short in a rare bid to overturn a governor's veto ...
Mixed reception for Minnesota law on hemp-derived cannabinoid products
Written by CBD-Intel || 17th June 2022 || Regulatory briefing |
A new law makes Minnesota the first state in the US to apply a 21+ age restriction to all hemp-derived cannabinoid products regardless of potential for intoxication ...
Changes ahead in Rhode Island as adult recreational cannabis sales are legalised
Written by CBD-Intel || 16th June 2022 || Regulatory briefing |
Cannabis will be available for recreational use in Rhode Island from 1st December after governor Dan McKee signed the Rhode Island Cannabis Act into law, making the state the 19th in the US to legalise adult use ...
Data gaps in EU novel food applications will be difficult, slow and costly to fill
Written by Tiziana Cauli || 15th June 2022 || Regulatory briefing |
CBD companies say they do not know when or even how they will be able to provide the missing data that has caused the European Food Safety Authority (EFSA) to pause the clock on assessing novel food applications...
How do you tell if a user is under the influence? It’s still a testing problem
Written by CBD-Intel || 14th June 2022 || Regulatory briefing |
While cannabis use is now legal in many US states, there is as yet no reliable test to determine whether, or how far, a user may be “under the influence” ...
State bank regulators call for America Competes to incorporate SAFE Act
Written by Tiziana Cauli || 13th June 2022 || Regulatory briefing |
US state bank regulators have asked Congress to provide legal cannabis businesses with access to financial services by integrating a bill preventing banks from being penalised for doing so into a broader law on innovation and competition ...
California cannabis cultivation tax stands to be eliminated imminently
Written by CBD-Intel || 10th June 2022 || Regulatory briefing |
Tax on the cultivation of cannabis in California could be eliminated as of July ...
Can a California cannabis cultivation tax cut help some without harming others?
Written by Freddie Dawson || 9th June 2022 || Blog , Regulatory briefing |
Could lowering taxes lead to more revenue? It’s a question that can be applied to many retail areas, from train tickets to electronics ...